ConductScience.org, home

Paper39141024

Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study.

Sullivan PS and 7 others. JMIR Form Res, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study. Papers, record 39141024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39141024

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study.
PubMed
Journal
JMIR Form Res
PubMed
Year
2024
PubMed
Publication types
Journal Article, Validation Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
1.0, provisional
iCite
Revised in PubMed
2025-05-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pre-Exposure ProphylaxisMajor topic
AlgorithmsMajor topic
TenofovirMajor topic
EmtricitabineMajor topic
HIV InfectionsMajor topic
Humans
Male
Female
Adult
Middle Aged
Anti-HIV Agents
Drug Prescriptions

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135678988Examining the Correlation Between PrEP Use and Black:White Disparities in HIV Incidence in the Ending the HIV Epidemic Priority Jurisdictions.J Gen Intern Med2023https://conductscience.org/library/papers/35678988PubMed
230714945Spatial Access and Willingness to Use Pre-Exposure Prophylaxis Among Black/African American Individuals in the United States: Cross-Sectional Survey.JMIR Public Health Surveill2019https://conductscience.org/library/papers/30714945PubMed
330730529Ending the HIV Epidemic: A Plan for the United States.JAMA2019https://conductscience.org/library/papers/30730529PubMed
432711800
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Lancet2020https://conductscience.org/library/papers/32711800PubMed
59595616Two-sided confidence intervals for the single proportion: comparison of seven methods.Stat Med1998https://conductscience.org/library/papers/9595616PubMed
630335734HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016.MMWR Morb Mortal Wkly Rep2018https://conductscience.org/library/papers/30335734PubMed
720128015Pharmacoepidemiological research using French reimbursement databases: yes we can!Pharmacoepidemiol Drug Saf2010https://conductscience.org/library/papers/20128015PubMed
827429893Development of a comprehensive measure of spatial access to HIV provider services, with application to Atlanta, Georgia.Springerplus2016https://conductscience.org/library/papers/27429893PubMed
930037634Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.Ann Epidemiol2018https://conductscience.org/library/papers/30037634PubMed
10843571The measurement of observer agreement for categorical data.Biometrics1977https://conductscience.org/library/papers/843571PubMed
1129229440Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.Lancet Infect Dis2018https://conductscience.org/library/papers/29229440PubMed
1231285182Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: a modelling study.Lancet HIV2019https://conductscience.org/library/papers/31285182PubMed
1332088073Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.Ann Epidemiol2020https://conductscience.org/library/papers/32088073PubMed
1423092060Interrater reliability: the kappa statistic.Biochem Med (Zagreb)2012https://conductscience.org/library/papers/23092060PubMed
1532578905Using electronic health records to identify candidates for human immunodeficiency virus pre-exposure prophylaxis: An application of super learning to risk prediction when the outcome is rare.Stat Med2020https://conductscience.org/library/papers/32578905PubMed
1635647866Association of Race and Other Social Determinants of Health With HIV Pre-Exposure Prophylaxis Use: A County-Level Analysis Using the PrEP-to-Need Ratio.AIDS Educ Prev2022https://conductscience.org/library/papers/35647866PubMed
1721091279Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.N Engl J Med2010https://conductscience.org/library/papers/21091279PubMed
1832097453Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012-2016.Clin Infect Dis2020https://conductscience.org/library/papers/32097453PubMed
1931222499Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals.Curr HIV/AIDS Rep2019https://conductscience.org/library/papers/31222499PubMed
2034379922Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.N Engl J Med2021https://conductscience.org/library/papers/34379922PubMed

See all 33 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41617214
Establish a PrEP (Pre-Exposure Prophylaxis) Epidemiology, Modeling, and Surveillance (PREMISE) System to Analyze Trends in PrEP Uptake and the Impact of PrEP Programs and Policies: Protocol for a Natural Experiment and Modeling Study in the United States.
JMIR Res Protoc2026https://conductscience.org/library/papers/41617214PubMed
41324957Telemedicine Preexposure Prophylaxis Prescribing From a Large Online US Company.JAMA Netw Open2025https://conductscience.org/library/papers/41324957PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39141024

GET https://conductscience.org/api/papers/v1/39141024/references?page=2